Cargando…

Successful secukinumab treatment in focal segmental glomerulosclerosis associated with plaque psoriasis

Detalles Bibliográficos
Autores principales: Cao, Zhiqiang, Liu, Zhaoyang, Zhu, Xia, Yang, Qinbo, Xu, Qingqing, Zhang, Chunhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116267/
https://www.ncbi.nlm.nih.gov/pubmed/35546261
http://dx.doi.org/10.1080/0886022X.2022.2073893
_version_ 1784710083240787968
author Cao, Zhiqiang
Liu, Zhaoyang
Zhu, Xia
Yang, Qinbo
Xu, Qingqing
Zhang, Chunhong
author_facet Cao, Zhiqiang
Liu, Zhaoyang
Zhu, Xia
Yang, Qinbo
Xu, Qingqing
Zhang, Chunhong
author_sort Cao, Zhiqiang
collection PubMed
description
format Online
Article
Text
id pubmed-9116267
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-91162672022-05-19 Successful secukinumab treatment in focal segmental glomerulosclerosis associated with plaque psoriasis Cao, Zhiqiang Liu, Zhaoyang Zhu, Xia Yang, Qinbo Xu, Qingqing Zhang, Chunhong Ren Fail Letter to the Editor Taylor & Francis 2022-05-11 /pmc/articles/PMC9116267/ /pubmed/35546261 http://dx.doi.org/10.1080/0886022X.2022.2073893 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Cao, Zhiqiang
Liu, Zhaoyang
Zhu, Xia
Yang, Qinbo
Xu, Qingqing
Zhang, Chunhong
Successful secukinumab treatment in focal segmental glomerulosclerosis associated with plaque psoriasis
title Successful secukinumab treatment in focal segmental glomerulosclerosis associated with plaque psoriasis
title_full Successful secukinumab treatment in focal segmental glomerulosclerosis associated with plaque psoriasis
title_fullStr Successful secukinumab treatment in focal segmental glomerulosclerosis associated with plaque psoriasis
title_full_unstemmed Successful secukinumab treatment in focal segmental glomerulosclerosis associated with plaque psoriasis
title_short Successful secukinumab treatment in focal segmental glomerulosclerosis associated with plaque psoriasis
title_sort successful secukinumab treatment in focal segmental glomerulosclerosis associated with plaque psoriasis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116267/
https://www.ncbi.nlm.nih.gov/pubmed/35546261
http://dx.doi.org/10.1080/0886022X.2022.2073893
work_keys_str_mv AT caozhiqiang successfulsecukinumabtreatmentinfocalsegmentalglomerulosclerosisassociatedwithplaquepsoriasis
AT liuzhaoyang successfulsecukinumabtreatmentinfocalsegmentalglomerulosclerosisassociatedwithplaquepsoriasis
AT zhuxia successfulsecukinumabtreatmentinfocalsegmentalglomerulosclerosisassociatedwithplaquepsoriasis
AT yangqinbo successfulsecukinumabtreatmentinfocalsegmentalglomerulosclerosisassociatedwithplaquepsoriasis
AT xuqingqing successfulsecukinumabtreatmentinfocalsegmentalglomerulosclerosisassociatedwithplaquepsoriasis
AT zhangchunhong successfulsecukinumabtreatmentinfocalsegmentalglomerulosclerosisassociatedwithplaquepsoriasis